Standard Life
US insurers turn to short-dated FX forwards as notionals rise
Counterparty Radar: Trades under three months make up nearly 60% of total positions, up from just a third in 2022
Insurance risk manager of the year: Standard Life
UK insurer’s risk function launched reviews of business and tech risks
Boards have no excuse for ignorance – Standard Life’s Grimstone
Need for strong boards, risk culture and internal audit emphasised at IIA conference
Q&A: Standard Life's Singh on changes in risk management
Regulation and tough markets put risk centre-stage, says CRO
Insurers fear non-recognition of equivalence under Solvency II interim reporting requirements
Group supervisors to determine whether European or local rules apply to non-European entities
Insurers assess partial models to reflect risk profile
Risk reflection
Insurers push for new way to recognise equivalence of Canada
Regime recognition mechanism proposal should be agreed in Omnibus II, says Standard Life's Porteous
Keeping above the capital floor
Keeping above the capital floor
Insurers stress liquidity and lapse risk amid concern over interest rate spike
When surrender is an option
Getting to grips with the Orsa challenge
The Orsa challenge
Insurers look to optimise curve-fitting technique
The learning curve
Insurers look to hedging strategies to deal with management charge volatility
Securing future value
Solvency II set to boost interest in variable annuities
Bright new hope?
Solvency II: obstacles and opportunities
Solvency II: obstacles and opportunities
Sponsored webinar: Solvency II
Obstacles and opportunities arise from Solvency II
Obstacles and opportunities of Solvency II
Webinar discusses the challenges faced by the insurance sector in implementing Solvency II
UK industry asks European Commission for certainty on Solvency II transition
UK industry asks European Commission for certainty on Solvency II transition
The View on Flu
Should life companies worry about bird flu? Swiss Re says yes, but Munich Re and a host of primary insurers claim the risks can be overstated. Richard Irving reports